Ballard Spahr advised John Rock, Inc. on the deal. Pallet manufacturer John Rock, Inc. announced the sale of the assets of five of its entities to Kamps,...
Kamps’ Acquisition of John Rock Entities’ Assets
Apex’s Acquisition of Eni’s Assets in Egypt
Bracewell advised IEOC Production B.V., a subsidiary of Eni S.p.A., on the deal. Herbert Smith Freehills advised Apex International Energy. Walkers acted as Cayman counsel to...
CooperVision’s Acquisition of SynergEyes
Carter Ledyard advised CooperVision on the deal. In November 2022, Carter Ledyard client CooperVision, Inc. completed its acquisition of SynergEyes, Inc. and its broad range of...
SirionLabs’ Series D Funding Round
Cooley advised Brookfield Growth on the deal. Brookfield Growth, the technology investment arm of Brookfield Asset Management, announced its investment of $25 million in SirionLabs’ Series D...
Arcadia’s $125 Million Funding Round
Cooley advised Arcadia on the deal. Arcadia, a technology company empowering energy innovators to fight the climate crisis, announced its $125 million in new funding. Magnetar Capital...
Leeds Equity Partners’ Acquisition of e.Republic Platform
Reed Smith advised Leeds Equity Partners on the deal. Leeds Equity Partners announced its platform acquisition of e.Republic, a California-based media, research, data, and events company...
North Bridge’s $42 Million C-PACE Loan to HB Capital Group
Reed Smith advised North Bridge on the deal. North Bridge, a sustainable financing lender and servicer, announced a $42 million commercial property assessed clean energy (C-PACE) loan...
TRexBio’s Collaboration and License Agreement with Lilly
Ropes & Gray advised TRexBio on the deal. TRexBio in a multi-year research collaboration and exclusive worldwide license agreement with Eli Lilly and Company to develop...
Scipher Medicine’s Acquisition of CrossBridge
Ropes & Gray represented Scipher Medicine on the deal. Precision immunology company Scipher Medicine announced its acquisition of data, analytics and software company CrossBridge to enhance...
CANbridge Pharmaceuticals’ License Agreement with UMass Chan Medical School
Ropes & Gray represented CANbridge Pharmaceuticals on the deal. CANbridge Pharmaceuticals, a China-based biopharmaceutical company, announced its exclusive worldwide license agreement with UMass Chan Medical School relating...
Shoreline Equity Partners’ Closing Of Shoreline Equity Partners Fund II
Ropes & Gray advised Shoreline Equity Partners on the deal. Shoreline Equity Partners, LLC announced the closing of its second private equity fund, Shoreline Equity Partners Fund...
Clinscience’s Investment in OncoBay
Ropes & Gray advised Moffitt Cancer Center and OncoBay Clinical on the deal. OncoBay obtained an investment from Clinscience, a global clinical research organization based in Warsaw,...